A detailed history of Orion Portfolio Solutions, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 17,531 shares of PRTA stock, worth $273,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,531
Previous 16,792 4.4%
Holding current value
$273,132
Previous $346,000 15.32%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$16.73 - $24.79 $12,363 - $18,319
739 Added 4.4%
17,531 $293,000
Q2 2024

Aug 13, 2024

BUY
$19.54 - $26.15 $129,628 - $173,479
6,634 Added 65.31%
16,792 $346,000
Q1 2024

May 09, 2024

BUY
$24.75 - $40.66 $19,750 - $32,446
798 Added 8.53%
10,158 $251,000
Q4 2023

Feb 09, 2024

BUY
$32.31 - $52.32 $302,421 - $489,715
9,360 New
9,360 $340,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $731M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.